Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; * excluding ophthalmic pharmaceutical preparations *

'anemia':16 'anoxia':26 'anoxia-induc':25 'blood':7 'cancer':15 'cell':8 'cellular':28,33 'congest':20 'degener':29,34 'exclud':37 'failur':22,24 'heart':21 'human':6 'hypoxia':31 'hypoxia-induc':30 'induc':27,32 'infarct':19 'ischemia':17 'myocardi':18 'ophthalm':38 'pharmaceut':1,10,39 'prepar':40 'product':9 'renal':23 'stimul':5 'stroke':36 'treatment':13 'use':3

ZYNTESA

Owners

Goods & Services